
Pimozide Augmentation Therapy in Treatment-Resistant…
Archives of Neuropsychiatry
Turn its ideas into short, game-like lessons you’ll actually finish.
About Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine
Giris Sizofreni tedavisinde yeterli doz ve surede tipik ve atipik antipsikotik ilac kullanilmasina ragmen hastalarin %2030'unda kismi yanit ya da yanitsizlik gorulmektedir (1). Sizofrenide tedaviye yanitsizlik, iki farkli kimyasal gruptan olmak uzere antip-sikotiklerin, 400600 mg/gun klorpromazin es degeri dozlarinda 46 hafta sure ile kullanilmasi sonunda %20'den daha az yanit alinmasi veya ilaca intolerans olarak tanimlanmaktadir (2). Tedaviye direncli sizofreni ise bircok otorite tarafindan tanimlanmis olmakla birlikte, Teksas Tedavi Algoritmasi (The Texas Medication Algorithm Project) atipik antipsikotikler ile en az 46 hafta suresince 2 ya da 3 kez tedavi denemesine yeterli yanit alinamadiginda 'tedaviye direncli sizofreni' kabul etmektedir (3). Tedaviye direncli sizofreni taniminda diger kabul goren olcutler, suregen pozitif psikotik belirtiler (Kisa Psikiyatrik Degerlendirme Olcegi (KPDO) 4 pozitif belirtiden en az ikisinin [greater than or equal to]4 puan olmasi), orta siddette ve suregen hastalik (KPDO [greater than or equal to]45 ve KGIS [greater than or equal to]4) ve son 5 yilda sosyal ve/veya mesleki islevsellikte iyilik donemi olmamasidir (4,5).
A smarter reading
and learning experience.
Hooked from page one.Every lesson opens on a question you want to answer, so your mind stays on it instead of drifting off.



Get it in seconds.Right after you answer, a few plain words show why. No dense chapters to push through.

Use it this week.Pick the moment you’ll use the idea in your own life, so it turns into a habit, not a highlight.

Questions about Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine
What is Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine about?
Giris Sizofreni tedavisinde yeterli doz ve surede tipik ve atipik antipsikotik ilac kullanilmasina ragmen hastalarin %2030'unda kismi yanit ya da yanitsizlik gorulmektedir (1).
Who wrote Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine?
Archives of Neuropsychiatry wrote Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine.
Is there a summary of Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine?
MEMRBL doesn’t summarize it. It turns its ideas into short lessons on your iPhone: you guess first, see why, and plan where you’ll use each idea this week.
How do I remember what I read in Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine?
Answer questions about it instead of reading it again. Recalling an idea makes it stick better than rereading it (Pan and Sana, 2021). That is how every MEMRBL lesson works.
What books are like Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine?
Hypomania in a Schizophrenic Patient Treated with Modafinil for Clozapine-Induced Sedation/Bir Sizofreni Hastasinda Klozapin Tedavisine Modafinil Eklenmesi Ile Ortaya Cikan Hipomani, Stahl's Essential Psychopharmacology and Intermittent Fasting For Women. See all books like Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine.
Books like Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine
See allExplore more books
Put Pimozide Augmentation Therapy in Treatment-Resistant Schizophrenia Patients with Poor Or Partial Response to Clozapine to work.
Short lessons on your iPhone. Free to download.




